发明名称 TRYPSIN-LIKE SERINE PROTEASE INHIBITORS, THEIR PREPARATION AND USE AS SELECTIVE INHIBITORS OF THE CLOTTING FACTORS IIA AND XA
摘要 The invention provides methods of making and using compounds of the formula (I) or a pharmaceutically acceptable salt thereof; wherein n is an integer between 1 and 2 inclusively; m is an integer between 0 and 2 inclusively; X is selected from the group consisting of CH or N; R1 is selected from the group consisting of -CH2NH2, and (Formula (II)); R2 is selected from the group consisting of -H, -OH, -NH2 and acetyl; R3 is selected from the group consisting of -H, benzyloxycarbonyl and benzyisulfonyl;and R4 is selected from the group consisting of -OH, (Formulae (III), (IV), (V), (VI)), wherein p is an integer between 0 and 2 inclusively, Y is selected from the group consisting of -0-, -S-, -S(=0)-, -S02-, methylene, -CH(OH)-, -CH(NH2)-, -CH(CH2-OH)-, -CH(CH2- NH2)- or -N(R6)-, R5 is selected from the group consisting of -H or a simple (C1-C3) alkyl and R6 is selected from the group consisting of -H, a simple (C1-C3) alkyl or a simple (C1-C3) acyl. These compounds are useful as anticoagulant agents as a result of their selective dual inhibition of thrombin and prothrombinase.
申请公布号 CA2822350(A1) 申请公布日期 2012.06.28
申请号 CA20112822350 申请日期 2011.12.21
申请人 THE MEDICINES COMPANY (LEIPZIG) GMBH 发明人 HEROLD, PETER;JELAKOVIC, STJEPAN;DAGHISH, MOHAMMED;REICHELT, CLAUDIA;SCHULZE, ALEXANDER;SCHWEINITZ, ANDREA;LUDWIG, FRIEDRICH-ALEXANDER;FAR, ADEL RAFAI;KANG, TING
分类号 C07K5/078;A61K38/05;A61P7/06;A61P9/00;C07D205/04;C07D207/16;C07D211/60;C07D295/192;C07D401/12;C07D403/12;C07D405/12;C07K5/06;C07K5/072 主分类号 C07K5/078
代理机构 代理人
主权项
地址